Piper Jaffray Calls Imperva (IMPV) Top Pick for 2nd-Half; Lifts PT to $80
Tweet Send to a Friend
Piper Jaffray analyst Andrew Nowinski reiterated an Overweight rating and boosted his price target on Imperva (NYSE: IMPV) to $80.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
